July 11, 2022
1 min learn
Trogdon is employed by HarborPath. Schmidt is employed by FFF Enterprises.
HarborPath, a North Carolina-based nonprofit group offering life-saving drugs in 17 states, introduced a partnership with FFF Enterprises to distribute naloxone to fight the opioid disaster.
In a press launch, HarborPath said its goal to bolster native efforts by introducing a multistate strategy to deploying naloxone by way of nonprofit organizations, county well being departments, faculty and college well being facilities, or on to shoppers.
Greater than 100,000 Americans died of opioid overdoses within the 12 months ending April 2021, up sharply from about 78,000 throughout the identical interval the yr earlier than, in accordance with the U.S. CDC information offered within the launch.
“We chosen FFF Enterprises as our unique distributor as a result of they share our similar values,” Ken Trogdon, president of HarborPath, said within the launch. “By utilizing our collective experience and assets to beat this horrible disaster, we are going to save the lives of these caught within the grip of habit.”
With amenities positioned in North Carolina, Texas and California, FFF Enterprises will act as unique distributor by way of its subsidiary, Nufactor, which affords naloxone free by way of a discreet, safe, direct-to-consumer mannequin. HarborPath will act because the nonprofit group contracting immediately with states, counties, cities and different nonprofits to supply this life-saving medication.
Most not too long ago, HarborPath awarded a grant to fund a full-time place in Kentucky for the nonprofit Operation UNITE to give attention to making naloxone extra obtainable and accessible all through a 32-county space ravaged by the opioid disaster.
“We’re happy HarborPath chosen us to work with them on this effort to avoid wasting lives affected by the opioid disaster,” Patrick M. Schmidt, CEO of FFF Enterprises stated within the launch. “The first aim of offering residents and communities affected by opioid use dysfunction simpler entry to a life-saving medicine is one thing we will wholeheartedly help.”